Target Price | CHF166.08 |
Price | CHF136.90 |
Potential | 21.31% |
Number of Estimates | 27 |
27 Analysts have issued a price target Richemont 2026 . The average Richemont target price is CHF166.08. This is 21.31% higher than the current stock price. The highest price target is CHF202.20 47.70% , the lowest is CHF137.44 0.39% . | |
A rating was issued by 30 analysts: 16 Analysts recommend Richemont to buy, 14 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Richemont stock has an average upside potential 2026 of 21.31% . Most analysts recommend the Richemont stock at Purchase. |
Mar '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion CHF | 19.80 | 19.85 |
0.10% | 0.21% | |
EBITDA Margin | 30.52% | 27.84% |
5.56% | 8.80% | |
Net Margin | 11.64% | 10.03% |
7,788.05% | 13.87% |
27 Analysts have issued a sales forecast Richemont 2025 . The average Richemont sales estimate is CHF19.8b . This is 1.29% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF21.0b 7.04% , the lowest is CHF19.1b 2.43% .
This results in the following potential growth metrics:
2024 | CHF19.8b | 0.10% |
---|---|---|
2025 | CHF19.8b | 0.21% |
2026 | CHF21.1b | 6.12% |
2027 | CHF22.5b | 6.73% |
2028 | CHF24.3b | 8.04% |
2029 | CHF27.6b | 13.48% |
24 Analysts have issued an Richemont EBITDA forecast 2025. The average Richemont EBITDA estimate is CHF5.5b . This is 2.24% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF5.9b 4.34% , the lowest is CHF4.6b 19.32% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | CHF6.0b | 5.65% |
---|---|---|
2025 | CHF5.5b | 8.59% |
2026 | CHF6.1b | 10.30% |
2027 | CHF6.7b | 10.64% |
2028 | CHF7.3b | 7.71% |
2024 | 30.52% | 5.56% |
---|---|---|
2025 | 27.84% | 8.80% |
2026 | 28.94% | 3.95% |
2027 | 30.00% | 3.66% |
2028 | 29.91% | 0.30% |
11 Richemont Analysts have issued a net profit forecast 2025. The average Richemont net profit estimate is CHF2.0b . This is 58.84% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF2.2b 79.60% , the lowest is CHF944m 24.61% .
This results in the following potential growth metrics and future Net Margins:
2024 | CHF2.3b | 7,780.00% |
---|---|---|
2025 | CHF2.0b | 13.73% |
2026 | CHF3.7b | 87.16% |
2027 | CHF4.2b | 13.23% |
2028 | CHF4.7b | 10.63% |
2024 | 11.64% | 7,788.05% |
---|---|---|
2025 | 10.03% | 13.87% |
2026 | 17.68% | 76.27% |
2027 | 18.76% | 6.11% |
2028 | 19.21% | 2.40% |
Mar '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share CHF | 3.94 | 3.40 |
7,780.00% | 13.71% | |
P/E | 40.28 | |
EV/Sales | 3.96 |
11 Analysts have issued a Richemont forecast for earnings per share. The average Richemont EPS is CHF3.40 . This is 58.88% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF3.84 79.44% , the lowest is CHF1.61 24.77% .
This results in the following potential growth metrics and future valuations:
2024 | CHF3.94 | 7,780.00% |
---|---|---|
2025 | CHF3.40 | 13.71% |
2026 | CHF6.36 | 87.06% |
2027 | CHF7.20 | 13.21% |
2028 | CHF7.97 | 10.69% |
Current | 63.99 | 37.41% |
---|---|---|
2025 | 40.28 | 37.05% |
2026 | 21.52 | 46.57% |
2027 | 19.01 | 11.66% |
2028 | 17.18 | 9.63% |
Based on analysts' sales estimates for 2025, the Richemont stock is valued at an EV/Sales of 3.96 and an P/S ratio of 4.04 .
This results in the following potential growth metrics and future valuations:
Current | 4.01 | 1,504.00% |
---|---|---|
2025 | 3.96 | 1.34% |
2026 | 3.73 | 5.76% |
2027 | 3.49 | 6.30% |
2028 | 3.23 | 7.44% |
2029 | 2.85 | 11.88% |
Current | 4.09 | 1,127.40% |
---|---|---|
2025 | 4.04 | 1.27% |
2026 | 3.81 | 5.76% |
2027 | 3.57 | 6.30% |
2028 | 3.30 | 7.44% |
2029 | 2.91 | 11.88% |
Analyst | Rating | Action | Date |
---|---|---|---|
JEFFERIES |
Buy
➜
Buy
|
Unchanged | Apr 07 2025 |
BERENBERG |
Hold
➜
Hold
|
Unchanged | Apr 07 2025 |
HSBC |
Buy
➜
Buy
|
Unchanged | Mar 23 2025 |
ODDO BHF |
Buy
➜
Buy
|
Unchanged | Mar 19 2025 |
CHINA INTERNATIONAL CAPITAL CORPORATION LIMITED |
Neutral
➜
Neutral
|
Unchanged | Mar 19 2025 |
BANCO SANTANDER |
Outperform
➜
Outperform
|
Unchanged | Mar 19 2025 |
TD COWEN |
Hold
➜
Buy
|
Upgrade | Mar 17 2025 |
Analyst Rating | Date |
---|---|
Unchanged
JEFFERIES:
Buy
➜
Buy
|
Apr 07 2025 |
Unchanged
BERENBERG:
Hold
➜
Hold
|
Apr 07 2025 |
Unchanged
HSBC:
Buy
➜
Buy
|
Mar 23 2025 |
Unchanged
ODDO BHF:
Buy
➜
Buy
|
Mar 19 2025 |
Unchanged
CHINA INTERNATIONAL CAPITAL CORPORATION LIMITED:
Neutral
➜
Neutral
|
Mar 19 2025 |
Unchanged
BANCO SANTANDER:
Outperform
➜
Outperform
|
Mar 19 2025 |
Upgrade
TD COWEN:
Hold
➜
Buy
|
Mar 17 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.